Last updated: Oct 30, 2026, 12:00 AM

Immunovant Inc Exchange (NASDAQ, USD)

IMVT

28.88
+0.71 (+2.52%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
52.48%
3 year return (CAGR)
-6.26%
5 year return (CAGR)
26.80%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
5.97B
Price/Sales
840.77
Ent value
5.28B
Price/Book
8.11
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
17.75%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open28.06
Daily high28.96
Daily low28.00
Daily Volume1.06M
All-time high52.71
1y analyst estimate48.88
Beta0.81
EPS (TTM)-2.62
Dividend per share0.00
Ex-div date-
Next earnings date18 Feb 2026

Ready to capitalize on Immunovant Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
IMVTS&P500
Current price drop from All-time high-45.21%-1.21%
Highest price drop-93.59%-56.47%
Date of highest drop16 Jun 20229 Mar 2009
Avg drop from high-50.11%-10.65%
Avg time to new high24 days12 days
Max time to new high1492 days1805 days